WALTHAM, Mass.--(BUSINESS WIRE)--Correlagen Diagnostics, Inc. (www.correlagen.com), a leading provider of genetic testing services, today announced that it is offering a genetic test for Hypertrophic Cardiomyopathy (HCM), an inherited disease that affects one out of 500 Americans. HCM is the leading cause of sudden cardiac death in children and young adults and accounts for 40 percent of all deaths on athletic playing fields across the U.S.